Skip to content

Navigation Surgery for Bone and Soft Tissue Tumor

Navigation Surgery for Bone and Soft Tissue Tumor

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01179698
Enrollment
45
Registered
2010-08-11
Start date
2009-01-31
Completion date
2010-12-31
Last updated
2010-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Tumors

Keywords

computer-assisted surgery, bone tumor, We will evaluate whether computer-assisted surgery, will be feasible and safe for bone tumor resection

Brief summary

Bone tumor near the articular cartilage is hard to remove sufficiently without damaging adjacent joint. The purpose of this study was to evaluate the feasibility of navigation-assisted surgery for saving joint in bone tumor resection or curettage. In this study, the investigators hypothesized that computer-assisted surgery is feasible method to get both enough margin and joint salvage. Each of them is important intermediate factor for either oncologic outcome or functional outcome respectively. The investigators designed this study to find what proportion of patients who underwent computer-assisted resection could get enough margins using some criteria obtained by overlapping preoperative and postoperative images. The investigators also evaluated whether computer-assisted surgery can be feasible for joint saving using some criteria including functional outcome.

Interventions

In en bloc resection, the osteotomy sites were determined by navigation guidance. For curettage, we monitored curette in real-time with navigation.

In en bloc resection, the osteotomy sites were determined by navigation guidance. For curettage, we monitored curette in real-time with navigation.

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

1. First condition is that the benign tumor is located deeply in bones of extremities, or pelvis, so we anticipate the difficulty to find the tumor and to assess the adequacy of resection without the aid of computer-assisted navigation during operation. 2. Second condition is when the violation of joint or growth plate is expected during removal of tumor due to its close proximity to joint or growth plate. In case of malignant bone tumor, the sufficient preservation of joint anatomy should be required even with resection margin of 1.5 cm away from reactive zone of tumor. The sufficient preservation of joint is defined when at least 1 cm subchondral bone is remained after tumor resection, because 1 cm subchondral bone is required for fixation with allograft in subsequent reconstruction. The sufficient preservation of joint is also defined when articular surface is removed, but more than 50% of articular surface has to be saved.

Exclusion criteria

were 1. Patients who denied to perform navigation surgery after explanation of navigation surgery protocol 2. Medically high-risk patients who could not withstand long surgical time for joint reconstruction 3. Patients whose feasibility of joint preservation was not fulfill the above inclusion criteria at initial presentation, although the tumor size was decreased enough to fulfill the inclusion criteria in MRI after completion of neoadjuvant chemotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Resection margin and safetyDay 1 - During operationPre-operative and post-operative CT or MRI images were fused using image fusion application of navigation software (Striker, Mahwah, NJ)in order to evaluate the resection margin.

Secondary

MeasureTime frameDescription
Oncological outcome and functional scorePostoperative 6 month and 12month1\) Oncological outcome after 6 month or 12 month from surgery like patient survival or tumor recurrence (tumor recurrence was diagnosed with PET CT or MRI according to the nature of original tumor), 2) functional scores were assessed by evaluation systems of the Musculoskeletal Tumor Society (MSTS)and Toronto Extremity Salvage Score (TESS).

Countries

South Korea

Contacts

Primary ContactSung Wook Seo
sungwook.seo@samsung.com
Backup ContactHee Jung Jin, bachelor's degree
jin8077.jin@samsung.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026